Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts

This publication has 13 references indexed in Scilit:

• Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]
  British Journal of Cancer, 1995
• Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity
  British Journal of Cancer, 1995
• Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study
  British Journal of Cancer, 1992
• Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection
  British Journal of Cancer, 1991
• Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine
  British Journal of Cancer, 1990
• Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours
  British Journal of Cancer, 1987
• Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (I). Centrifugal elutriation
  British Journal of Cancer, 1987
• Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survival
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Reductive fragmentation of 2-nitroimidazoles: Amines and aldehydes
  International Journal of Radiation Oncology*Biology*Physics, 1984